Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - SANUWAVE Health, Inc. | snwv_ex991.htm |
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of report
(Date of earliest event reported): May 18,
2020
SANUWAVE Health, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Nevada
|
|
000-52985
|
|
20-1176000
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
3360 Martin Farm Road, Suite 100
Suwanee, Georgia 30024
(Address of Principal Executive Offices, and Zip Code)
(770) 419-7525
Registrant’s Telephone Number, Including Area
Code
(Former Name or Former Address, if Changed Since Last
Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Exchange
Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common
stock, par value $0.001 per share
|
|
SNWV.QB
|
|
OTC
Bulletin Board
|
Indicate
by check mark whether the registration is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or
Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 2.02 Results
of Operations and Financial Condition.
On May
18, 2020, SANUWAVE Health, Inc., a Nevada Corporation (the
"Company"), announced its financial results for the three months
ended March 31, 2020 and provided a business update via conference
call. A copy of the related press release is furnished as
Exhibit 99.1 to
this Form 8-K.
The
information in this Item 2.02 of this Current Report on Form 8-K
and the exhibit attached hereto shall not be deemed to be "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and shall not be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such
filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
Press release,
dated May 18, 2020, issued by SANUWAVE Health, Inc., titled
“SANUWAVE Health reports first quarter 2020 financial
results.”
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
||
|
|
SANUWAVE HEALTH, INC.
|
|
||
|
Date:
May 18, 2020
|
By:
|
/s/
Lisa E.
Sundstrom
|
|
|
|
|
|
Lisa E.
Sundstrom
|
|
|
|
|
|
Controller
and Chief Financial Officer
|
|
|